Blog

ITUS Enters CAR-T Research Alliance with Moffitt Cancer Center – PR Newswire (press release)

ITUS Enters CART Research Alliance with Moffitt Cancer Center
PR Newswire (press release)
This CAR-T technology is initially focused on Ovarian Cancer, by engineering killer Tcells with the Follicle Stimulating Hormone (FSH) to target ovarian cells that express the FSH-Receptor. The FSH-Receptor was shown to be a very exclusive protein

and more »

2017-11-20 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.